Literature DB >> 34098217

Agrimol B present in Agrimonia pilosa Ledeb impedes cell cycle progression of cancer cells through G0 state arrest.

Su Su Thae Hnit1, Rongzhen Ding2, Ling Bi2, Chanlu Xie1, Mu Yao1, Paul De Souza3, Ling Xu2, Zhong Li4, Qihan Dong5.   

Abstract

Cancer recurrence poses a significant challenge. At the cellular level, recurrence takes place as a result of reactivation of dormant cancer cells residing at G0 phase. The aim of the study was to identify compounds that can trap prostate and lung cancer cells in G0 phase from a new Chinese herb recipe, Astringent recipe, consisting of Radix Paeoniae Alba, Agrimonia pilosa Ledeb, Fructus Mume, Fritillaria thunbergii Miq., Ganoderma Lucidum Karst, and Astragalus membranaceus (Fisch.) Bunge. Astringent recipe impeded cell cycle progression in prostate and lung cancer cells by rounding them up at G0 phase by flow cytometric analysis of cancer cells stained with Hoechst 33342 and Pyronin Y, respectively, for DNA and RNA. The anti-cancer efficacy of the recipe was found to be attributable to Agrimonia pilosa Ledeb. Further study established that agrimol B, a polyphenol derived from Agrimonia pilosa Ledeb, contributed to the activity of the herb. The action of agrimol B on the cancer cells was likely derived from its effect on c-MYC, SKP2 and p27 by immunoblotting and immunofluorescence. Oral administration of Agrimonia pilosa Ledeb or agrimol B reduced growth of prostate cancer cell xenograft in animal. In conclusion, Agrimol B can enrich for prostate and lung cancer cells in G0 state and influence key regulators that govern G0 status.
Copyright © 2021 The Authors. Published by Elsevier Masson SAS.. All rights reserved.

Entities:  

Keywords:  Agrimol B; Ellagic acid; Lung cancer; Polyphenols; Prostate cancer; Quiescent cancer cells

Mesh:

Substances:

Year:  2021        PMID: 34098217     DOI: 10.1016/j.biopha.2021.111795

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  5 in total

1.  Apigenin impedes cell cycle progression at G2 phase in prostate cancer cells.

Authors:  Su Su Thae Hnit; Mu Yao; Chanlu Xie; Ling Bi; Matthew Wong; Tao Liu; Paul De Souza; Zhong Li; Qihan Dong
Journal:  Discov Oncol       Date:  2022-06-07

2.  Astragalus-Scorpion Drug Pair Inhibits the Development of Prostate Cancer by Regulating GDPD4-2/PI3K/AKT/mTOR Pathway and Autophagy.

Authors:  Xujun You; Yongrong Wu; Qixin Li; Wen Sheng; Qing Zhou; Wei Fu
Journal:  Front Pharmacol       Date:  2022-06-29       Impact factor: 5.988

Review 3.  Agrimonia pilosa: A Phytochemical and Pharmacological Review.

Authors:  Tianyu Jin; Li Chi; Chongyang Ma
Journal:  Evid Based Complement Alternat Med       Date:  2022-04-29       Impact factor: 2.650

4.  Proteomics Analysis of Antitumor Activity of Agrimonia pilosa Ledeb. in Human Oral Squamous Cell Carcinoma Cells.

Authors:  Tae-Young Kim; Kwang-Soo Koh; Ji-Min Ju; Yeon-Ju Kwak; Soo-Kyung Bae; Hye-Ock Jang; Da-Sol Kim
Journal:  Curr Issues Mol Biol       Date:  2022-07-25       Impact factor: 2.976

Review 5.  Agrimonia pilosa Ledeb.: A review of its traditional uses, botany, phytochemistry, pharmacology, and toxicology.

Authors:  Sihua Wen; Xiaofei Zhang; Yanan Wu; Shangshang Yu; Wei Zhang; Ding Liu; Kai Yang; Jing Sun
Journal:  Heliyon       Date:  2022-07-21
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.